News
-
-
PRESS RELEASE
2024 FULL YEAR RESULTS
-
-
-
PRESS RELEASE
Medacta Group SA reports significant above-market revenue growth of 16.2% in constant currency in 2024
Medacta Group SA reports 16.2% revenue growth in constant currency in 2024, driven by all geographic markets and business lines. CEO Francesco Siccardi expresses pride in team's achievements -
-
PRESS RELEASE
Sunrise issues a new USD 1,300 million Term Loan B due 2032 to refinance existing USD Term Loan B due 2029 and partially refinance existing EUR Term Loan B due 2029
Sunrise issues a new USD 1,300 million Term Loan B due 2032 to refinance existing loans and enhance sustainability, reducing cost of debt. Deutsche Bank, Citi lead the issuance -
REGULATED PRESS RELEASE
NFL Biosciences publie les résultats positifs d’un programme complémentaire confirmant l’excellent profil de sécurité de NFL-101, son traitement first in class contre l’addiction au tabac
NFL Biosciences publie des résultats positifs d'un programme complémentaire confirmant le profil de sécurité de son traitement NFL-101 contre l'addiction au tabac -
REGULATED PRESS RELEASE
NFL Biosciences publishes positive results from a complementary program confirming the excellent safety profile of NFL-101, its first-in-class treatment for tobacco addiction
NFL Biosciences reports positive results from toxicity study on NFL-101, showing superior safety profile for tobacco addiction treatment, enhancing potential for Phase 3 development -
